S1P RECEPTOR MODULATORS FOR THE TREATMENT OF MULTIPLE SKLEROSE

摘要

Use of an S1P receptor modulator, such as a compound of formula I to IXb as defined above, in the manufacture of a drug for the prevention, inhibition or treatment of neoangiogenesis associated with demyelinating disease, such as multiple sclerosis.